Panacro Pharmaceutical Technology
PrivateLast Round
Series B
Dec 18, 2023
Total Funding Raised
$14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Panacro Pharmaceutical Technology operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B round in December 2023.
Panacro Pharmaceutical Technology is a contract research organization that provides clinical research and development services for pharmaceutical and biotechnology companies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panacro Pharmaceutical Technology Comparables
Compare Panacro Pharmaceutical Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bestudy (Shanghai) Medical Technology Co., Ltd. | 89% | |
| R&G PharmaStudies Co., Ltd. | 85% | |
| Yaoyanshe | 81% |
For institutional investors. Book with your work email.
Panacro Pharmaceutical Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 18, 2023 | ||||
| Series A | Apr 15, 2022 | ||||
| Strategic | Apr 6, 2020 | ||||
| Angel | Oct 27, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Panacro Pharmaceutical Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huatai Zijin Investment | Strategic, Angel |
| Addor Capital | Strategic, Angel |
| CoStone Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 220% MoM, reaching 1.4K.
- Apr 6, 2020
Huatai Zijin Investment and Addor Capital participated.
For institutional investors. Book with your work email.
Panacro Pharmaceutical Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Panacro Pharmaceutical Technology's valuation, stock price, and market status.
Is Panacro Pharmaceutical Technology a public or private company?
Panacro Pharmaceutical Technology is a private company.
What is the current stock price of Panacro Pharmaceutical Technology?
Panacro Pharmaceutical Technology is a private company, so its shares have no public market price. Caplight tracks Panacro Pharmaceutical Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Panacro Pharmaceutical Technology worth (valuation)?
Valuation information for Panacro Pharmaceutical Technology is not publicly available.
Can I buy Panacro Pharmaceutical Technology stock?
Panacro Pharmaceutical Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Panacro Pharmaceutical Technology's last funding round?
Panacro Pharmaceutical Technology's most recent funding round was Series B on December 18, 2023.
Who are the main investors in Panacro Pharmaceutical Technology?
Key investors in Panacro Pharmaceutical Technology include CoStone Capital.
Will Panacro Pharmaceutical Technology IPO soon?
No public IPO plans have been announced for Panacro Pharmaceutical Technology.
How can I track Panacro Pharmaceutical Technology secondary market activity?
Caplight tracks bids, offers, and trades in Panacro Pharmaceutical Technology's shares on secondary markets.